Cbay stock price target

31 Jan 2020 Those same analysts give the stock an average rating of Buy. That average rating puts CymaBay Therapeutics Inc higher than 18 of stocks, based 

19 Mar 2020 Apple stock received a price-target cut Thursday from Canaccord Genuity on expectations for a weak June quarter for iPhone sales. (CBAY) Company Bio. Cymabay Therapeutics, Inc. focuses on developing therapies to treat metabolic diseases. The company was formerly known as Metabolex,  Historical daily share price chart and data for CymaBay Therapeutics since 2020 adjusted for splits. The latest closing stock price for CymaBay Therapeutics as  14 Apr 2019 How Price Targets are Determined. A price target is an analyst's or trader's expectation of the future price of an asset, such as a stock, futures 

5 days ago Additionally, CBAY shares got another “Neutral” rating from ROTH Capital, setting a target price of $2 on the company's shares, according to the 

Find the latest CymaBay Therapeutics Inc. (CBAY) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 2.73  5 days ago Additionally, CBAY shares got another “Neutral” rating from ROTH Capital, setting a target price of $2 on the company's shares, according to the  Prev Close 1.48, 52 Wk Low 1.21. Open 1.49, 52 Wk High 13.75. Day Low 1.44, Volume 547,612.00. Day High 1.52, Avg 10D Vol 1.5M  Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, Cymabay Therapeutics to Outperform From Perform, Sets $4 Price Target. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed  CBAY investment & stock information. Get the latest CymaBay Therapeutics Inc . CBAY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for 

Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, Cymabay Therapeutics to Outperform From Perform, Sets $4 Price Target. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed 

Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for 

Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, Cymabay Therapeutics to Outperform From Perform, Sets $4 Price Target. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed  CBAY investment & stock information. Get the latest CymaBay Therapeutics Inc . CBAY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

6 Mar 2020 (NASDAQ:CBAY) is now rated as Neutral. Their price target on the stock stands at $2. Even though the stock has been trading at $1.84/share, 

CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CBAY updated stock price target summary. Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for  Stock Price Forecast for CBAY: Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate.

1 Oct 2019 The only reason insiders buy a company's stock is that they believe The average target price is $18.20, about 30% higher than where it is